Gufic Biosciences Limited
Motilal Oswal Mutual Fund, which previously held 3.32 percent of Gufic Biosciences Limited, has dropped off the disclosed shareholder list, indicating either a complete sale or a reduction to under the 1 percent reporting threshold.
A pharmaceutical manufacturer engaged in producing medicinal chemicals, botanical products, and finished pharmaceutical formulations for domestic and international markets. Gufic BioScience operates across multiple therapeutic segments, focusing on research-driven drug development and manufacturing of active pharmaceutical ingredients. The company combines traditional botanical expertise with modern pharmaceutical science to deliver diverse healthcare solutions across different treatment areas.
AMC arm of Motilal Oswal Financial Services, founded on the belief in long-term buy-and-hold quality investing. Manages over Rs 1.5 lakh crore. Famous for the QGLP (Quality, Growth, Longevity, Price) investment framework and concentrated portfolios with very low churn. Flagship Motilal Oswal Midcap and Motilal Oswal Flexi Cap funds reflect deep conviction positioning with 15-25 stock portfolios.